ICD-10 Coding for Peritoneal Cancer(C48.0, C48.2, C48.2B)

Explore ICD-10 coding for peritoneal cancer, including primary and secondary classifications, documentation requirements, and common pitfalls.

Also known as:
Peritoneal CarcinomatosisCarcinoma of PeritoneumPrimary Peritoneal Cancer
Related ICD-10 Code Ranges

Complete code families applicable to Peritoneal Cancer

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescription
C48.2Malignant neoplasm of peritoneum
C78.6Secondary malignant neoplasm of retroperitoneum and peritoneum

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information

Essential facts and insights aboutPeritoneal Cancer

Differential Codes

Alternative codes to consider when ruling out similar conditions

Secondary malignant neoplasm of retroperitoneum and peritoneumC78.6

Use when cancer has metastasized to the peritoneum from another primary site.

Malignant neoplasm of peritoneumC48.2

Use when the primary cancer originates in the peritoneum.

Documentation & Coding Risks

Avoid these common issues when documenting Peritoneal Cancer.

Failure to document primary cancer site

Impact

Clinical: Inaccurate treatment planning, Regulatory: Non-compliance with coding standards, Financial: Potential for denied claims

Mitigation

Verify primary site with imaging and biopsy, Include comprehensive documentation in patient records

Using C78.6 for primary peritoneal cancer

Impact

Reimbursement: Incorrect reimbursement due to misclassification, Compliance: Potential compliance issues with coding guidelines, Data Quality: Inaccurate cancer registry data

Mitigation

Verify and document the primary origin of the cancer.

Primary vs. Secondary Cancer Coding

Impact

Misclassification of primary and secondary peritoneal cancer can lead to audit findings.

Mitigation

Ensure thorough documentation and verification of cancer origin.

Frequently Asked Questions